Madison, CT, United States of America

Lila Adnane

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 10.7

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Madison, CT (US) (2009 - 2011)
  • Pine Brook, NJ (US) (2012)

Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Exploring the Innovations of Inventor Lila Adnane

Introduction: Inventor Lila Adnane, hailing from Madison, CT (US), is a pioneering figure in the field of biotechnology and pharmaceuticals, boasting an impressive portfolio of three patents that have significantly advanced the realms of cancer treatment and diagnosis.

Latest Patents:

1. "Anti-MN antibodies and methods of using same": Lila Adnane's groundbreaking invention provides antibodies with a specific antigenic binding site targeting an MN protein. These antibodies play a crucial role in the treatment and diagnosis of MN-related disorders, offering new avenues for precision medicine.

2. "Bicyclic urea derivatives useful in the treatment of cancer and other disorders": Another remarkable patent by Lila Adnane involves novel diaryl ureas that demonstrate efficacy in treating hyper-proliferative and angiogenesis disorders like cancer. These compounds hold immense promise as standalone agents or in combination with existing cytotoxic therapies.

Career Highlights: Lila Adnane is associated with Bayer Healthcare LLC, a renowned pharmaceutical company dedicated to developing innovative healthcare solutions. Through her tenure at Bayer Healthcare LLC, Lila has spearheaded various projects that have reshaped the landscape of medical research and treatment methodologies.

Collaborations: Lila Adnane has collaborated closely with esteemed professionals in the industry, including William Johnston Scott and Jacques P. Dumas. These collaborative efforts have led to synergistic innovations and groundbreaking discoveries, cementing her reputation as a collaborative and visionary inventor.

Conclusion: In conclusion, Lila Adnane's exceptional contributions to the fields of biotechnology and pharmaceuticals underscore her unwavering commitment to advancing healthcare standards globally. Her inventive spirit, coupled with a penchant for collaboration, continues to drive transformative changes in the realm of medical research and treatment, making her a notable figure in the realm of innovations and inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…